
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer&
Acquisition will strengthen MYND’s psilocybin-assisted medicinal and diagnostics capabilities, adding novel psychedelics for the...
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer&
MYND Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal for $3 Mil
MYND Life Sciences Inc. to Present at Psychedelics Virtual Investor Conference on October 13